In patients with early RA from PREMIER who were initiating MTX, the lowest P value for the difference in ACR responses between the PBO+MTX arm and the ADA+MTX arm and the greatest treatment difference was achieved at ACR60 (Fig. 1a) at week 26. Here, ADA is linked to rheumatoid arthritis.